Navigation Links
Emerging lymphoma and myeloma treatments focus on improving individual patient response
Date:12/12/2011

lon as a possible biomarker to improve treatment and patient outcomes in multiple myeloma," said senior author Keith Stewart, MD, Professor of Medicine in the Division of Hematology-Oncology at Mayo Clinic in Scottsdale, Ariz. "This work also suggests that we can begin to isolate the cause of birth defects from the anti-cancer properties in order to develop safer drugs in the future."

Yuan Xiao Zhu, PhD, will present this study in an oral presentation on Sunday, December 11, at 4:30 p.m. PST at the San Diego Convention Center in Room 6DE.

Final Analysis of a Randomized Comparison of ABVD Chemotherapy with a Strategy that Includes Radiation Therapy (RT) in Patients with Limited-Stage Hodgkin Lymphoma (HL): NCIC CTG/ECOG HD.6 [Abstract 590]

New research concludes that patients with limited-stage Hodgkin lymphoma treated with a standard chemotherapy regimen have better overall survival rates compared with those receiving a radiation-based treatment.

Patients with limited-stage Hodgkin lymphoma (HL) are often treated with combination therapy containing chemotherapy plus radiation (RT). While this therapy is successful in controlling HL, these patients remain challenged by potential long-term complications of radiation exposure such as heart conditions or subsequent cancers.

To determine if HL patients treated with standard chemotherapy (ABVD) have better long-term survival than those treated with radiation-based therapy, researchers from Canada's NCIC Clinical Trials Group (NCIC CTG) designed a trial comparing the 12-year overall survival (OS) between the two groups. The Eastern Cooperative Oncology Group (ECOG) also participated in the trial. Along with overall survival, the trial also examined secondary survival factors, including freedom from disease progression (FFDP) and event-free survival (EFS).

Approximately 400 patie
'/>"/>

Contact: Lindsey Love
llove@hematology.org
540-538-9326
American Society of Hematology
Source:Eurekalert

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Emerging public health crisis linked to mortgage default and foreclosure
2. Emerging pharmaceutical platform may pose risks to retinal health
3. Georgia Tech researchers receive 3 NSF Emerging Frontiers awards
4. ASCO: Emerging trends in radiation therapy for women over 70 with early stage breast cancer
5. ATS issues report on emerging issues in HIV-associated pulmonary disease
6. Emerging drug class may enhance red blood cell production in anemic patients
7. New Society for Social Neuroscience to help guide emerging field
8. Live streaming of emerging brain science and health news
9. Emerging E. coli strain causes many antimicrobial-resistant infections in US
10. Neuxpower Selected as 2010 Emerging Technology Vendor by CRN Magazine
11. Experts explore emerging evidence linking diabetes and cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... ... July 28, 2015 , ... ... that Schneider Electric has completed its upgrade and expansion of its ... with more than 170,000 employees in 134 countries supplying a wide range of ...
(Date:7/28/2015)... , ... July 28, 2015 , ... ... of Directors has authorized the Company, from time to time and depending on ... value of up to $25 million. Repurchases will be made in open market ...
(Date:7/28/2015)... ... July 28, 2015 , ... Women fear developing Alzheimer's disease ... that cancer, heart attack, and stroke are treatable, but there is little an individual ... is to take part in a clinical trial, reports the July 2015 Harvard ...
(Date:7/28/2015)... ... July 28, 2015 , ... A new study published by ... Study Says " sheds light on a possible new treatment option for people living ... of regular HBOT sessions, at least five per week, patients experienced a significant decrease ...
(Date:7/28/2015)... ... ... Most employers have been using multi-tier prescription drug plans for many years, but ... in the use of 4-tier plans, which typically cover the highest cost drugs, as ... to continue, according to UBA. , UBA’s survey finds that, since 2009, the number ...
Breaking Medicine News(10 mins):Health News:Schneider Electric Amps Up Its Use of Kinetic Data’s Enterprise Request Management Software 2Health News:Schneider Electric Amps Up Its Use of Kinetic Data’s Enterprise Request Management Software 3Health News:Schneider Electric Amps Up Its Use of Kinetic Data’s Enterprise Request Management Software 4Health News:Safeguard Scientifics Board of Directors Authorizes up to $25 Million Share Repurchase Program 2Health News:Safeguard Scientifics Board of Directors Authorizes up to $25 Million Share Repurchase Program 3Health News:Fight Alzheimer's By Taking Part in a Clinical Trial, From the July 2015 Harvard Women's Health Watch 2Health News:Fight Alzheimer's By Taking Part in a Clinical Trial, From the July 2015 Harvard Women's Health Watch 3Health News:Recovery Specialists Discuss How Oxygen Therapy Can Ease Fibromyalgia 2Health News:Recovery Specialists Discuss How Oxygen Therapy Can Ease Fibromyalgia 3Health News:Employers Use of Multi-Tier Pharmacy Benefits Continues to Rise 2Health News:Employers Use of Multi-Tier Pharmacy Benefits Continues to Rise 3Health News:Employers Use of Multi-Tier Pharmacy Benefits Continues to Rise 4Health News:Employers Use of Multi-Tier Pharmacy Benefits Continues to Rise 5
... LOS ANGELES, May 29 Writers and producers,from ... others were honored,at the 2008 Voice Awards last ... Administration (SAMHSA), hosted by award-winning actor and,mental health ... at Paramount Studios in Los Angeles., Winners ...
... ALOKA announced today new compact,ProSound ultrasound Systems which ... Federation of Societies for Ultrasound in Medicine and ... in Timisoara, Romania. The ProSound 2 is a,portable ... functions. High image quality technologies developed for,the premium ...
... The gene that allows fireflies to flash is helping ... UT Southwestern Medical Center researchers are among the first to ... used to determine the effectiveness of cancer drugs that choke ... requires a substrate called luciferin to be added to the ...
... More northern women feel bloating and,gurgling than their southern ... it at any one time, according to a TNS ... and Yorkshire and Humberside fared the,worst (71%), with Greater ... bloated feelings. And 61% of British women experience feeling,bloated, ...
... receiving the necessary symptom management that they require to ... its treatment, or both, according to a leading professor ... million people around the world (10 million in the ... newly diagnosed with cancer can expect to live at ...
... July 10 Cash Dividend ... - Preliminary Proxy Results, WALNUT CREEK, Calif., May 28 ... and the,preliminary proxy results at its 2008 Annual Meeting of Stockholders., ... dividend on common shares of $0.14 per share payable July,10, 2008 to ...
Cached Medicine News:Health News:SAMHSA Honors 'The Sopranos,' 'Monk,' 'Dirt' at Star-Studded Voice Awards in Los Angeles 2Health News:SAMHSA Honors 'The Sopranos,' 'Monk,' 'Dirt' at Star-Studded Voice Awards in Los Angeles 3Health News:SAMHSA Honors 'The Sopranos,' 'Monk,' 'Dirt' at Star-Studded Voice Awards in Los Angeles 4Health News:ALOKA to Unveil a New Compact 'ProSound' Diagnostic Ultrasound System 2Health News:Fireflies' glow helps UT Southwestern researchers track cancer drug's effectiveness 2Health News:Fireflies' glow helps UT Southwestern researchers track cancer drug's effectiveness 3Health News:North South Divide Exists in UK Digestive Health 2Health News:North South Divide Exists in UK Digestive Health 3Health News:Cancer survivors are living 'in limbo' with unmet needs for care 2Health News:Cancer survivors are living 'in limbo' with unmet needs for care 3Health News:Longs Drug Stores Corporation Announced at Its Annual Meeting of Stockholders 2
(Date:7/28/2015)... FORT WORTH, Texas , July 28, 2015 /PRNewswire/ ... Report "Global Dermatology Devices Market by Type (Dermatology Treatment ... MRI, CT), Dermatoscopes, Microscopes]), by Application, by Geography - ... market is expected to reach $11.88 billion by 2019, ... Browse through the TOC of Global Dermatology ...
(Date:7/28/2015)... , July 28, 2015 Research ... addition of the "Global Hearing Aids Market ... The global hearing aids market to grow ... 2014-2019. Factors such as changing ... driving market growth. The market has witnessed immense ...
(Date:7/28/2015)... 2015   CSL Behring announced today ... Authorization Application (MAA) for the company,s investigational long-acting ... recombinant albumin (rIX-FP) for the prophylaxis and treatment ... Upon Swissmedic approval, rIX-FP will provide hemophilia B ... intervals up to 14 days. ...
Breaking Medicine Technology:Global Dermatology Devices Market to be Worth $11.88 Billion by 2019 2Global Dermatology Devices Market to be Worth $11.88 Billion by 2019 3Global Hearing Aids Market 2015-2019 with G N Store Nord, Sonova Holdings & William Demant Dominating 2Swissmedic Accepts for Review CSL Behring's MAA for rIX-FP for Patients with Hemophilia B 2Swissmedic Accepts for Review CSL Behring's MAA for rIX-FP for Patients with Hemophilia B 3Swissmedic Accepts for Review CSL Behring's MAA for rIX-FP for Patients with Hemophilia B 4
... Phosphagenics,Limited (ASX: POH, AIM: PSG, OTCQX: PPGNY) today ... undertake a Phase 1 transdermal,oxycodone clinical trial aimed ... management product. Phosphagenics has submitted all necessary ... be conducted at CMAX - an independent clinical ...
... Phase 2 clinical development, PRINCETON, N.J., Sept. ... in the discovery and development of novel,small molecule ... 2a,clinical study of PS433540, the company,s lead internal ... receptor antagonist,(DARA) that is being developed as a ...
Cached Medicine Technology:Phosphagenics to Conduct a Phase 1 Transdermal Oxycodone Clinical Trial 2Pharmacopeia Initiates Phase 2 Hypertension Study with PS433540 (DARA) 2Pharmacopeia Initiates Phase 2 Hypertension Study with PS433540 (DARA) 3Pharmacopeia Initiates Phase 2 Hypertension Study with PS433540 (DARA) 4Pharmacopeia Initiates Phase 2 Hypertension Study with PS433540 (DARA) 5
... Intelli-Storeroom™ was developed to create physically secured ... and exits are converted to RFID portals. ... readers and antennas by VerdaSee's Field Engineering ... to assets that are to be tracked. ...
... Mobile Aspects provides hospitals ... products to track all their ... Our RFID systems remove all ... items and people accurately. iRIS, ...
The WatchMate LC model is a cost-effective solution for monitoring a single exit, and provides local notification of an alarm....
... AgileTrac Surgical Services is a Web-based ... to track, manage, and measure patient flow ... process, from admission to discharge. AgileTrac collects ... of care delays your patient might experience. ...
Medicine Products: